Similar Search Results

Change agents and the evolution of the United States pharmaceutical industry, 1920--1960

Lee, Jeho - 1996

This dissertation examines the evolution of the market and the firms in the context of an emerging innovative race in the U.S. pharmaceutical industry. The history shows the existence of two distinct industry regimes. Before 1940, the industry can best be characterized as a competitive regime in...

Persistent link: https://www.econbiz.de/10009439017

"Your Life is Waiting!": Symbolic Meanings in Direct-to-Consumer Antidepressant Advertising

Grow, Jean; Park, Jin Seong; Han, Xiaoqi - 2006

This semiotic analysis demonstrates how pharmaceutical companies strategically frame depression within the hotly contested terrain of direct-to-consumer (DTC) advertising. The study tracks regulation of the pharmaceutical industry, relative to DTC advertising, including recent industry codes of...

Persistent link: https://www.econbiz.de/10009484498

Consumer construction of the agricultural biotechnology industry's legitimacy: An empirical test of values congruency as institutional and actional legitimacy formation

Mosley, Raul A - 2006

institutional legitimacy) and to market drug-producing crops called Plant Made Pharmaceuticals (an instance of actional legitimacy …. Consumers were more slightly more likely to acknowledge the industry's right to market Plant Made Pharmaceuticals (r = .257 … as a big business entity and to market Plant Made Pharmaceuticals. …

Persistent link: https://www.econbiz.de/10009430368

A call to be whole : the fundamentals of health care reform

Sowada, Barbara J. - 2003

Persistent link: https://www.econbiz.de/10004796312

Analysis of corporate acquisitions by medical device manufacturers

DeGraaff, Robert A - 2006

This doctoral thesis draws on the financial economics, strategic management, product innovation, and health technology literatures to investigate and explain conditions under which corporate acquisitions in the medical device industry have enhanced or eroded shareholder wealth and financial...

Persistent link: https://www.econbiz.de/10009438806

Price regulation, capital market imperfections, and strategic R&D investment behavior in the pharmaceutical industry: Consequences for innovation

Vernon, John Andrew - 2003

The research in this thesis focuses on the pharmaceutical R&D investment decision. The two primary hypotheses I test are that: (1) capital market imperfections in the market for pharmaceutical R&D finance impart a lower cost of capital to internal funds relative to external debt and equity, and...

Persistent link: https://www.econbiz.de/10009439232

Hippocratic PostgreSQL

Padma, J; Silva, Yasin; Arshad, Mohamed; Aref, Walid - 2009

Privacy preservation has become an important requirement in information systems that deal with personal data. In many cases this requirement is imposed by laws that recognize the right of data owners to control whom their information is shared with and the purposes for which it can be shared....

Persistent link: https://www.econbiz.de/10009430509

Lean indicators in hospital/healthcare settings and the role of leadership in the diffusion of performance improvement strategies

Ezzeddine, Ahmad M - 2006

This study examines the process improvement initiatives undertaken at a community-based hospital to improve patient satisfaction and the financial and competitive position of the hospital through the implementation and marketing of the 29 Minute Emergency Department Guarantee. Specifically, the...

Persistent link: https://www.econbiz.de/10009431730

A new look at hospital cost function estimation

Velagapudi, Kalyani R Mandadi - 1995

The production of hospital care can be viewed as a two-tiered production process. At the first tier, intermediate services are produced which are used in the production of final services, which comprise the second tier of production. Intermediate services are not always produced internally. Some...

Persistent link: https://www.econbiz.de/10009431756

Did Michigan's policies reduce the daily cost of drug therapy for its dual eligible beneficiaries?

Kibicho, Jennifer Waruguru - 2007

Background . Michigan Medicaid outpatient prescription drug program implemented the following four policies to address rising expenditures considered "out of control": (1) February 2002: Preferred Drug List (PDL); (2) February 2003: Joint Purchasing Arrangement (JPA); (3) November 2003: Maximum...

Persistent link: https://www.econbiz.de/10009431783